• Thumbnail for Valneva COVID-19 vaccine
    Valneva SE in collaboration with the American biopharmaceutical company Dynavax Technologies. In April 2022, the United Kingdom Medicines and Healthcare...
    18 KB (1,318 words) - 13:22, 28 March 2024
  • Thumbnail for MVC COVID-19 vaccine
    developed by Medigen Vaccine Biologics Corporation in Taiwan, American company Dynavax Technologies, and the U.S. National Institutes of Health. This vaccine...
    15 KB (1,455 words) - 14:15, 9 March 2024
  • and IC41, therapeutic vaccine against hepatitis C. Valneva along with Dynavax Technologies developed a candidate inactivated whole virus vaccine against...
    12 KB (997 words) - 22:21, 31 December 2023
  • Thumbnail for Corbevax
    Vaccine Development and Baylor College of Medicine in Houston, Texas and Dynavax technologies based in Emeryville, California. It is licensed to Indian...
    16 KB (1,211 words) - 17:20, 19 February 2024
  • Thumbnail for Hepatitis B vaccine
    hepatitis B virus infection (HBV). The applicant for this medicinal product is Dynavax GmbH. It was approved for medical use in the European Union in February...
    57 KB (5,164 words) - 14:40, 9 April 2024
  • Thumbnail for Biological E. Limited
    a pact with Baylor College of Medicine, Texas Children's Hospital and Dynavax Technologies to develop a COVID-19 vaccine. The vaccine Corbevax/Bio E...
    7 KB (544 words) - 19:46, 25 February 2024
  • Thumbnail for SCB-2019
    vaccine developed by Clover Biopharmaceuticals using an adjuvant from Dynavax technologies. Positive results of Phase I trials for the vaccine were published...
    15 KB (1,444 words) - 06:17, 7 January 2024
  • Realty Trust Set to Join S&P MidCap 400; Alpha and Omega Semiconductor & Dynavax Technologies to Join S&P SmallCap 600" (PDF). S&P Dow Jones Indices. May...
    250 KB (7,604 words) - 14:08, 9 April 2024
  • Realty Trust Set to Join S&P MidCap 400; Alpha and Omega Semiconductor & Dynavax Technologies to Join S&P SmallCap 600" (PDF). May 12, 2022. Retrieved May...
    227 KB (4,804 words) - 08:53, 3 April 2024
  • United States VLA2001 is an inactivated vaccine developed by Valneva SE and Dynavax Technologies. Full (1) United Kingdom Emergency (32) Bahrain United Arab...
    318 KB (19,351 words) - 20:33, 14 March 2024